Identifying the disease-causing mechanisms in cancers with unknown primary site improves treatment
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013) [1], will hear on Monday. In up to five percent of all cancers, ...
Sep 30, 2013
0
0